Sutent
Pfizer halts Sutent colon cancer trial
July 2, 2009Research and Development, Sales and Marketing Cancer, Pfizer, Sutent
Pfizer has halted a phase III trial for its oncology hope Sutent, after it failed to show significant improvement in …
Pfizer halts Sutent head-to-head trial
April 6, 2009Research and Development, Sales and Marketing Cancer, Pfizer, Sutent
Pfizer has halted a late-stage breast cancer trial between Sutent and Roche's Xeloda, after the study failed to show significant …
NICE recommends Pfizer’s Sutent
March 26, 2009Research and Development NICE, Pfizer, Sutent
NICE has issued its final guidance on Pfizer's Sutent, recommending the kidney cancer drug as a first-line treatment. The drug …
Pfizer switches agencies in time for Sutent’s UK launch
August 18, 2006Medical Communications Reynolds-Mackenzie, Sutent
Pfizer has enlisted PR agency Reynolds-Mackenzie to support the UK launch and subsequent development of its potential blockbuster kidney cancer …
Latest content
Long-acting therapies set to reshape HIV treatment market
August 21, 2026
MHRA approves Romvimza for tenosynovial giant cell tumour
August 20, 2026
